Secretion of prostaglandins as bone-resorbing agents by renal cortical carcinoma in culture.
Fragments of human renal carcinoma tissue have been co-cultured with mouse calvaria. In 9/13 cases significant bone resorption occurred whilst in no case did control kidney cause significant resorption. When bone resorption did occur, it could be reduced by inclusion of indomethacin in the culture medium. In some cases when theophylline was included in culture medium to prevent cyclic AMP breakdown, there was enhancement of tumour-induced bone resorption. Control studies without tumour showed that none of the experimental treatments had a direct effect on bone. Radioimmunoassay of prostaglandin E (PGE) levels in pooled culture media showed that tumour fragments produced appreciable amounts of PGE, and that this production was lowered by indomethacin and increased by theophylline. It is concluded that the bone resorption induced by these tumours is due to a prostaglandin, and that prostaglandin production may be controlled by changes in cyclic AMP metabolism.
D000818:Animals; D001862:Bone Resorption / Q000187:drug effects; D000242:Cyclic AMP / Q000378:metabolism; D006801:Humans; D066298:In Vitro Techniques; D007213:Indomethacin / Q000494:pharmacology; D007672:Kidney Cortex; D007680:Kidney Neoplasms / Q000378:metabolism*; D051379:Mice; D010281:Parathyroid Hormone / Q000378:metabolism; D011453:Prostaglandins / Q000378:metabolism*; D011458:Prostaglandins E / Q000378:metabolism; D013806:Theophylline / Q000494:pharmacology
D010281:Parathyroid Hormone; D011453:Prostaglandins; D011458:Prostaglandins E; D013806:Theophylline; D000242:Cyclic AMP; D007213:Indomethacin